SCHEMBL16623465

SCHEMBL16623465

N=C(c1ccc(S)cc1)c1c(Nc2ccccc2Cl)cc[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.45
APAF1 O14727 1/20 0.34
TDP2 O95551 1/20 0.34
CDC25B P30305 1/20 0.34
CASP3 P42574 1/20 0.34
CASP7 P55210 1/20 0.34
CASP9 P55211 1/20 0.34
CASP6 P55212 1/20 0.34
CASP8 Q14790 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CXCL8 P10145 1/20 0.34
TTBK1 Q5TCY1 1/20 0.34
TTBK2 Q6IQ55 1/20 0.34
PARP1 P09874 1/20 0.34
C1R P00736 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623561 0.86 EGFR (0.45) EGFRPARP1C1RALDH1A1SMN1; SMN2
SCHEMBL16623553 0.86 MAPK14 (0.35) EGFRCDC25BCXCL8PARP1C1R
SCHEMBL16623591 0.83 AKR1C3 (0.38) EGFRPARP1ALDH1A1KDM4EMAPT
SCHEMBL16623558 0.79 PARP1 (0.34) PARP1
SCHEMBL16623570 0.78 PARP1 (0.31) PARP1
SCHEMBL16726659 0.75 JAK2 (0.34) JAK2JAK1
SCHEMBL16623492 0.74
SCHEMBL16623464 0.72 JAK1 (0.38) JAK2JAK1
SCHEMBL16623488 0.71 JAK1 (0.33) JAK2JAK1
SCHEMBL16623542 0.71 JAK1 (0.39) KDM4EJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed